Psychiatrist Dr. Christie Mensch works with adult patients at Wyandot Center, a mental health facility located in Kansas City, Kansas. Dr. Christie Mensch’s associates at Wyandot participate in the Zero Suicide Initiative, thanks to funding from the Health Care Foundation of Greater Kansas City. This program is part of the 2012 National Strategy for Suicide Prevention and works to prevent suicide deaths in people who are being cared for in various health care systems.
This program takes a big-picture, systemic approach to suicide prevention. It understands that practitioners require broader support and education in order to best help their patients. The Zero Suicide Initiative accordingly focuses on fostering leadership, providing training, and continually improving the level of care that practitioners offer.
At Wyandot, this training has helped practitioners. Therapists report feeling as though their efforts matter more and are more valuable to patients. The Zero Suicide Initiative has also highlighted the importance of particular skills, such as refuting harmful cognitive distortions.
Dr. Christie Mensch serves as a psychiatrist at Kansas City’s Wyandot Center, where she provides outpatient services to a diverse population. Since assuming this role, Dr. Christie Mensch has treated many patients with clinical depression.
Although clinical depression is treatable, provided the patient has access to the resources of talk therapy and medication, there is no reliable way to prevent depression. However, neuroscientist and entrepreneur Rebecca Brachman has identified a drug that may help increase the brain’s resistance to the kind of stress that can lead to depressive symptoms.
The discovery came when Dr. Brachman and her team were working with laboratory mice that had been given the drug ketamine, which is used to address severe depression. When placed into another study testing resistance to stress, these same mice were immune to the depressive symptoms that researchers expected from animals put through significantly stressful situations. This occurred even though the mice were weeks out of their ketamine regimen.
Dr. Brachman is currently working on translating this discovery into the development of a drug that physicians can use to prevent depression in persons going into stressful situations. While recipients of the drug will not be immune to the stress itself, the drug may enable faster recovery.
Psychiatrist Christie Mensch serves patients at the Wyandot Center, a mental health facility in Kansas City, Kansas. In her daily work, Christie Mensch diagnoses and treats mental health issues in adults.
The Wyandot Center offers a full range of mental health and recovery services to individuals who have experienced mental health disorders. The center’s valuable services are open to adults who live in Wyandotte County and the greater Kansas City area.
Crisis support is of key importance at the Wyandot Center. There are several ways for community members to access immediate mental health services when in need. The walk-in crisis clinic on 47th Street is open daily from 8 a.m. to 5 p.m. Clinic therapists are ready to assist anyone who comes in, and appointments are not necessary.
The Wyandot Center also operates a 24-hour crisis hotline. Anyone experiencing emotional distress may call the hotline for assistance from a qualified mental professional. The hotline number is (913) 788-4200.
Dr. Christie Mensch serves as a psychiatrist at the Wyandot Center in Kansas City, Kansas. There, Dr. Christie Mensch diagnoses and treats depression and other mental illnesses.
Clinical depression is much more than a passing sad feeling. Such emotions are normal reactions to life’s difficult times, but when they continue unabated or occur alongside other physical or emotional symptoms, they may be signs of a serious mental illness.
Individuals with depression may feel persistently sad, although feelings of anxiety, emptiness, or hopelessness are just as common. These feelings may occur alongside thoughts of guilt or worthlessness, as well as a loss of interest in activities that the person had once enjoyed. Energy can decrease significantly, and the person may feel like sleeping much of the time, although some patients are more prone to have trouble sleeping as opposed to oversleeping.
Similarly, people with depression may either overeat or not feel like eating much at all. They may complain of stomach aches, cramps, or headaches, even if these complaints do not have a clear physical cause or do not respond to treatment.
One of the most serious signs of depression is suicidal ideation or attempted suicide. Sometimes these thoughts and intentions come with verbal signs, such as the person’s stating that the world would be better without him or her. Frequent references to death and reckless behavior are common. Experts urge loved ones and patients alike to take these signs seriously and to seek help immediately.
Dr. Christie Mensch is a psychiatrist based in Kansas City, Kansas. She practices at the Wyandot Center, which offers comprehensive outpatient mental health services. Dr. Christie Mensch is especially interested in the treatment and study of depression.
While doctors have long understood that there is a link between psychological and physical health, more recently they’ve begun to see links between mental illness and major risk factor illnesses like heart disease. Depression has been linked to chronic pain, stress, digestive disorders, and early death, but it is now being linked to heart health, especially cardiovascular disease.
Studies show that the relationship is mutual: those with heart conditions are more likely to become depressed and those who have depression are more likely to develop heart disease. A recent German study, which observed 3,500 men between the ages of 45 and 74, showed that the risk of fatal heart disease was as high in men with depression as it was in men suffering from obesity or high cholesterol levels. Scientists don’t yet know the link, but they hypothesize that stress hormones play a role.
A psychiatrist at the Wyandot Center in Kansas City, Kansas, Dr. Christie Mensch provides full service mental health care in an outpatient setting. Dr. Christie Mensch evaluates and treats a variety of mental health concerns, including schizophrenia.
Schizophrenia is a chronic disorder of the brain. It can cause people to experience delusions, hallucinations, and difficulties with concentration and thinking. If a friend or loved one has a schizophrenia diagnosis, there are simple things you can do to help them.
– Encourage them to get treatment or remain in treatment. There are many trials and studies available as well, many of which offer promising new treatments and therapies.
– Be patient, and recognize their right to their own views. People who live with schizophrenia commonly hold demonstrably false beliefs, but these can seem very real to them. Be as respectful as possible without supporting inappropriate or destructive behavior.
– Be aware of the risk of substance abuse. People who live with schizophrenia tend to be at high risk for drug and alcohol abuse, which can also adversely affect treatment.
Canine Chemotherapy Trials
Psychiatrist Dr. Christie Mensch offers outpatient mental health services to patients at the Wyandot Center in Kansas City, Kansas. Alongside her commitment to her own patients’ medical care, Dr. Christie Mensch supports the University of Kansas Medical Center’s valuable work.
The University of Kansas Medical Center is dedicated to educating healthcare professionals and providing high-quality medical care to the people of Kansas. It is also a regional hub for medical research, and has made significant advancements in the understanding of Alzheimer’s, various cancers, and other conditions in recent years.
The University of Kansas Medical Center has enjoyed a recent success with an injectable chemotherapy trial for dogs. HylaPlat, the drug being tested, is a combination of cisplatin and hyaluronan. The compound was injected directly into cancerous oral tumors on seven large breed canine trial participants, all of whom were pets, not laboratory animals.
Two of the first seven dogs experienced partial remission, and three others were cancer-free after the trial. These encouraging results and an accompanying news story inspired dog owners around the world to get in touch with Kansas researchers, who ultimately opened the trials to dogs of all sizes and with varying types of cancers.
This trial is still accepting patients. If your dog is a cancer patient, you may get in touch with researchers by emailing firstname.lastname@example.org.